Trial intelligence / Profile preview

Summers Non-Pesticide Lice Asphyxiator for Head Lice

NCT00479310Phase 3Completed

Sponsor
Summers Laboratories
Start
Jan 2006
Modality
Nanoparticles, Small Molecules
01

Overview

Phase 3, randomised, double-blind trial in pediculosis capitis comparing Summers 5% L.A with Vehicle Control (2 arms). Primary endpoint: Treatment success defined as the absence of live lice. Started Jan 2006; status: completed.

02

Drugs

Summers 5% L.A.
03

Conditions

pediculosis capitis

Beyond the preview

Go deeper on NCT00479310.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00479310.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call